Alyeska Investment Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
2018
Q2
$1.23M Buy
2018
Q1
$1.65M Sell
2017
Q4
$2.14M Hold
2017
Q3
$2.36M Buy
2017
Q2
$1.71M Sell
2017
Q1
$6.5M Buy
2016
Q4
$5.31M Sell
2016
Q3
$9.96M Buy
2016
Q2
$5.32M Buy
2016
Q1
$3.29M Buy
2015
Q4
$3.59M Sell
2015
Q3
$3.43M Buy
2015
Q2
$4.22M Buy
2015
Q1
$4.11M Sell
2014
Q4
$5.5M Sell
2014
Q3
$5.73M Buy
2014
Q2
$5.83M Sell
2014
Q1
$8.81M Sell
2013
Q4
$8.25M Buy
2013
Q3
$4.12M Buy